Skip to content
Health Vitamin
Nutrients, Fact Checked
  • Deficiency Watch
  • Dosage Science
  • Nutrient Pairings
  • Supplement Reviews
  • Vitamin Guides
AstraZeneca wins in lung cancer, loses in breast cancer

AstraZeneca wins in lung cancer, loses in breast cancer

by Zoey Campbell • -215 minutes ago
AbbVie seeks broader Qulipta use after trial success

AbbVie seeks broader Qulipta use after trial success

by Ani Permata • 18 hours ago
Bionyra Begins Phase I BYN-001 Dosing in Volunteers

Bionyra Begins Phase I BYN-001 Dosing in Volunteers

by Zoey Campbell • 2 days ago
Beeline Medicines’ lupus drug trial succeeds in key test

Beeline Medicines’ lupus drug trial succeeds in key test

by Ani Permata • 3 days ago

Vitamin Guides

PROTAC Oral Exposure Challenge Demands Early Developer Action

PROTAC Oral Exposure Challenge Demands Early Developer Action

by Athirah Zaman • Sep 3, 2026
The Legal Landscape of Delta 8 Gummies 1000mg

The Legal Landscape of Delta 8 Gummies 1000mg

by Zoey Campbell • Aug 30, 2026

Nutrient Pairings

Beeline Medicines’ lupus drug trial succeeds in key test
Nutrient Pairings

Beeline Medicines’ lupus drug trial succeeds in key test

by Ani Permata • 3 days ago
PharmSci 360 Adds Credibility and Post‑Animal Tracks
Nutrient Pairings

PharmSci 360 Adds Credibility and Post‑Animal Tracks

by Ani Permata • Sep 2, 2026
Merck and Moderna Unveil Personalized Cancer Vaccine
Nutrient Pairings

Merck and Moderna Unveil Personalized Cancer Vaccine

by Ani Permata • Sep 1, 2026
Florida’s Rising Trend: Why Emsella Chairs Are in High Demand
Nutrient Pairings

Florida’s Rising Trend: Why Emsella Chairs Are in High Demand

by Zoey Campbell • Aug 30, 2026

MOST READ

  • PROTAC Oral Exposure Challenge Demands Early Developer Action
    PROTAC Oral Exposure Challenge Demands Early Developer Action
  • The Science Behind Hormone Replacement Therapy: What You Need to Know
    The Science Behind Hormone Replacement Therapy: What You Need to Know
  • Florida’s Rising Trend: Why Emsella Chairs Are in High Demand
    Florida’s Rising Trend: Why Emsella Chairs Are in High Demand
  • Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
    Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
  • Bionyra Begins Phase I BYN-001 Dosing in Volunteers
    Bionyra Begins Phase I BYN-001 Dosing in Volunteers
  • AstraZeneca wins in lung cancer, loses in breast cancer
    AstraZeneca wins in lung cancer, loses in breast cancer

LATEST NEWS

AstraZeneca wins in lung cancer, loses in breast cancer
Deficiency Watch
AstraZeneca wins in lung cancer, loses in breast cancer
-215 minutes ago
AbbVie seeks broader Qulipta use after trial success
Supplement Reviews
AbbVie seeks broader Qulipta use after trial success
18 hours ago
Bionyra Begins Phase I BYN-001 Dosing in Volunteers
Vitamin Guides
Bionyra Begins Phase I BYN-001 Dosing in Volunteers
2 days ago
Beeline Medicines’ lupus drug trial succeeds in key test
Nutrient Pairings
Beeline Medicines’ lupus drug trial succeeds in key test
3 days ago
Imfinzi and Imdelltra combo wins Phase III in SCLC
Dosage Science
Imfinzi and Imdelltra combo wins Phase III in SCLC
4 days ago
Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
Deficiency Watch
Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
5 days ago
Scientists uncover enzyme activity with advanced cell imaging
Vitamin Guides
Scientists uncover enzyme activity with advanced cell imaging
6 days ago
Cancer Vaccine Uses COVID Memory to Target Tumors
Vitamin Guides
Cancer Vaccine Uses COVID Memory to Target Tumors
Sep 7, 2026
Bionyra Begins Phase I BYN-001 Dosing in Volunteers
Vitamin Guides
Bionyra Begins Phase I BYN-001 Dosing in Volunteers
Zoey Campbell • 2 days ago
Scientists uncover enzyme activity with advanced cell imaging
Scientists uncover enzyme activity with advanced cell imaging
6 days ago
Cancer Vaccine Uses COVID Memory to Target Tumors
Cancer Vaccine Uses COVID Memory to Target Tumors
Sep 7, 2026
Novo Nordisk’s ziltivekimab fails Phase 3 trial
Novo Nordisk’s ziltivekimab fails Phase 3 trial
Sep 4, 2026
Beeline Medicines’ lupus drug trial succeeds in key test
Nutrient Pairings
Beeline Medicines’ lupus drug trial succeeds in key test
Ani Permata • 3 days ago
PharmSci 360 Adds Credibility and Post‑Animal Tracks
PharmSci 360 Adds Credibility and Post‑Animal Tracks
Sep 2, 2026
Merck and Moderna Unveil Personalized Cancer Vaccine
Merck and Moderna Unveil Personalized Cancer Vaccine
Sep 1, 2026
Florida’s Rising Trend: Why Emsella Chairs Are in High Demand
Florida’s Rising Trend: Why Emsella Chairs Are in High Demand
Aug 30, 2026
AstraZeneca wins in lung cancer, loses in breast cancer
Deficiency Watch
AstraZeneca wins in lung cancer, loses in breast cancer
Zoey Campbell • -215 minutes ago
Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
5 days ago
AbbVie seeks broader Qulipta use after trial success
Supplement Reviews
AbbVie seeks broader Qulipta use after trial success
Ani Permata • 18 hours ago
AbbVie’s Maviret cures 96% in trial, world challenges
AbbVie’s Maviret cures 96% in trial, world challenges
Aug 31, 2026

Deficiency Watch

AstraZeneca wins in lung cancer, loses in breast cancer

AstraZeneca wins in lung cancer, loses in breast cancer

by Zoey Campbell • -215 minutes ago
Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors

Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors

by Zoey Campbell • 5 days ago

Supplement Reviews

Supplement Reviews

AbbVie seeks broader Qulipta use after trial success

by Ani Permata • 18 hours ago
AbbVie seeks broader Qulipta use after trial success
AbbVie’s Maviret cures 96% in trial, world challenges
by Athirah Zaman • Aug 31, 2026
AbbVie’s Maviret cures 96% in trial, world challenges

BETTER LIVING

Beeline Medicines’ lupus drug trial succeeds in key test

Beeline Medicines’ lupus drug trial succeeds in key test

By Ani Permata • 3 days ago
Imfinzi and Imdelltra combo wins Phase III in SCLC

Imfinzi and Imdelltra combo wins Phase III in SCLC

By Ani Permata • 4 days ago
Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors

Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors

By Zoey Campbell • 5 days ago

Dosage Science

Imfinzi and Imdelltra combo wins Phase III in SCLC

Imfinzi and Imdelltra combo wins Phase III in SCLC

by Ani Permata • 4 days ago
The Science Behind Hormone Replacement Therapy: What You Need to Know

The Science Behind Hormone Replacement Therapy: What You Need to Know

by Zoey Campbell • Aug 30, 2026

ALL POST

AstraZeneca wins in lung cancer, loses in breast cancer
Deficiency Watch

AstraZeneca wins in lung cancer, loses in breast cancer

by Zoey Campbell • -215 minutes ago
AbbVie seeks broader Qulipta use after trial success
Supplement Reviews

AbbVie seeks broader Qulipta use after trial success

by Ani Permata • 18 hours ago
Bionyra Begins Phase I BYN-001 Dosing in Volunteers
Vitamin Guides

Bionyra Begins Phase I BYN-001 Dosing in Volunteers

by Zoey Campbell • 2 days ago
Beeline Medicines’ lupus drug trial succeeds in key test
Nutrient Pairings

Beeline Medicines’ lupus drug trial succeeds in key test

by Ani Permata • 3 days ago
Imfinzi and Imdelltra combo wins Phase III in SCLC
Dosage Science

Imfinzi and Imdelltra combo wins Phase III in SCLC

by Ani Permata • 4 days ago
Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
Deficiency Watch

Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors

by Zoey Campbell • 5 days ago
Scientists uncover enzyme activity with advanced cell imaging
Vitamin Guides

Scientists uncover enzyme activity with advanced cell imaging

by Ani Permata • 6 days ago
Cancer Vaccine Uses COVID Memory to Target Tumors
Vitamin Guides

Cancer Vaccine Uses COVID Memory to Target Tumors

by Ani Permata • Sep 7, 2026
Novo Nordisk’s ziltivekimab fails Phase 3 trial
Vitamin Guides

Novo Nordisk’s ziltivekimab fails Phase 3 trial

by Ani Permata • Sep 4, 2026
PROTAC Oral Exposure Challenge Demands Early Developer Action
Vitamin Guides

PROTAC Oral Exposure Challenge Demands Early Developer Action

by Athirah Zaman • Sep 3, 2026
1 2 Next page

Latest Post

  • AstraZeneca wins in lung cancer, loses in breast cancer
  • AbbVie seeks broader Qulipta use after trial success
  • Bionyra Begins Phase I BYN-001 Dosing in Volunteers
  • Beeline Medicines’ lupus drug trial succeeds in key test
  • Imfinzi and Imdelltra combo wins Phase III in SCLC
  • Gilead, Nucleai Investigate ADC Resistance in Target-Positive Tumors
  • Scientists uncover enzyme activity with advanced cell imaging

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Sitemap
  • Terms of Service

Social Media

Facebook Facebook
YouTube YouTube
Twitter Twitter / X
Instagram Instagram
Health Vitamin

Nutrients, Fact Checked

Categories

  • Vitamin Guides
  • Nutrient Pairings
  • Deficiency Watch
  • Supplement Reviews
  • Dosage Science

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Terms of Service
  • Sitemap

Latest Post

  • AstraZeneca wins in lung cancer, loses in breast cancer
  • AbbVie seeks broader Qulipta use after trial success
  • Bionyra Begins Phase I BYN-001 Dosing in Volunteers
  • Beeline Medicines’ lupus drug trial succeeds in key test
  • Imfinzi and Imdelltra combo wins Phase III in SCLC
© 2026 Health Vitamin. All Rights Reserved.